Wholesale Respiratory Devices for Chile
FDA-registered Resvent ventilators and CPAP/BiPAP systems with duty-free access under the US-Chile FTA and ISP registration support.
Healthcare spending above the OECD average with 100% tariff-free access for U.S. medical devices since 2015.
Chile allocates 10.5% of GDP to healthcare — above the 9.3% OECD average. Respiratory diseases spike during winter months, frequently exceeding public hospital capacity in Santiago and Concepción, driving consistent ventilator and CPAP procurement.
Respiratory Equipment for Institutional Buyers
ISP Device Registration
Chile's ISP (Instituto de Salud Pública) operates a well-structured regulatory framework closely aligned with international standards — which works in favor of FDA-cleared devices. Registration is submitted through the ANDID-001 form, requires an Authorized Body for conformity assessment, and typically takes approximately 75 working days from submission. Filing fees are roughly USD 350. All Resvent respiratory devices hold active ISP registrations.
Required documentation includes: Certificates of Free Sale, FDA 510(k) summaries, ISO 13485 quality system certificates, device risk analysis (ISO 14971), and instructions for use translated to Chilean Spanish. Chile's regulatory alignment with IMDRF (International Medical Device Regulators Forum) means that well-prepared FDA submissions translate relatively cleanly into ISP filings — fewer surprises, fewer requests for additional information.
FTA Duty-Free Access & Southern Cone Logistics
The US-Chile Free Trade Agreement has eliminated 100% of bilateral tariffs since January 2015. Every qualifying U.S.-origin medical device enters Chile at 0% duty — a straightforward competitive advantage over European and Asian suppliers who face standard MFN rates.
The trade-off is geography. Chile is the farthest LATAM market from Miami, and that distance shows up in lead times. Ocean freight to San Antonio or Valparaíso runs 25–35 business days. Air freight to Santiago SCL cuts that to 2–5 days for urgent orders but at significantly higher per-unit cost. Customs clearance through Chile's Servicio Nacional de Aduanas is generally efficient and predictable — one of the more transparent processes in the region. SysMed provides pre-formatted export documentation including commercial invoices, FTA certificates of origin, and harmonized tariff classifications.
Navigating FONASA, ISAPRE & CENABAST Procurement
Chile's dual public-private financing system creates two distinct demand channels. On the public side, FONASA covers approximately 78% of the population, and device procurement for public hospitals is increasingly centralized through CENABAST (Central de Abastecimiento del Sistema Nacional de Servicios de Salud). CENABAST tenders follow structured timelines and documentation requirements. On the private side, ISAPRE plans cover higher-income segments, and private clinic groups run independent purchasing with faster decision cycles.
SysMed supports Chilean distributors with bilingual account management, ISP renewal coordination, and clinical training materials for respiratory therapy departments. We help partners position for both CENABAST tenders and private-sector supply agreements across Santiago (which concentrates roughly 30% of national hospital capacity), Valparaíso, and Concepción.
SysMed powers smarter respiratory care
Regulatory Compliance & Certifications
Cloud-Connected for Value-Added Services
20+ Years of Experience in LATAM Markets
Getting Started is Simple
1. Talk with Our Wholesale Team
Get expert guidance on product selection, regulatory requirements, and logistics, available in English and Spanish.
2. Logistics Coordination
Work with us to arrange your shipment, ensuring accurate tracking and complete, compliant documentation.
3. Post-Sale Support
Whether it’s documentation or technical assistance after delivery, we’re here to support you every step of the way.
Frequently Asked Questions
What is CENABAST and how does it centralize medical device procurement in Chile?
CENABAST (Central de Abastecimiento del Sistema Nacional de Servicios de Salud) is Chile's centralized public procurement agency for healthcare supplies. It purchases medical devices, pharmaceuticals, and equipment on behalf of the public hospital network, consolidating demand into large-volume national tenders.
For respiratory device distributors, CENABAST tenders represent the highest-volume public-sector opportunity in Chile. The process follows structured timelines with specific documentation and pricing requirements. On the private side, ISAPRE plans and private clinic groups run independent purchasing with faster decision cycles. SysMed helps distributors prepare for both tracks — CENABAST tender documentation and private-sector supply proposals.
What duty rate applies to U.S. respiratory devices entering Chile under the FTA?
Zero — across the board. The US-Chile Free Trade Agreement has eliminated 100% of bilateral tariffs since January 2015. Every qualifying U.S.-origin medical device enters Chile at 0% duty, with no phase-in periods or tariff-rate quotas remaining.
This gives U.S. suppliers a direct cost advantage over European and Asian competitors, who face Chile's standard MFN (Most Favored Nation) rates. SysMed provides FTA certificates of origin with every shipment for clearance through Chile's Servicio Nacional de Aduanas.
How does Chile's ISP alignment with IMDRF standards benefit FDA-cleared device importers?
Chile's ISP is a member of the IMDRF (International Medical Device Regulators Forum), which harmonizes regulatory requirements across participating countries including the U.S., EU, Japan, Australia, and Canada. In practice, this means the technical documentation format ISP expects closely mirrors what FDA and other IMDRF members require.
For importers with FDA-cleared devices, the benefit is concrete: your existing FDA submission materials — 510(k) summaries, quality system evidence, risk management files — translate into ISP filings with minimal reformatting. Fewer information requests during review, fewer document gaps, and faster time to registration. This isn't the case in markets with less internationally aligned regulatory systems.
How does Chile's ISP registration process work for FDA-cleared respiratory devices?
Registration is submitted through the ANDID-001 form and requires an Authorized Body for conformity assessment. The ISP typically processes submissions in approximately 75 working days, with filing fees around USD 350. Chile's alignment with IMDRF (International Medical Device Regulators Forum) standards means FDA-prepared documentation translates cleanly — fewer information requests and fewer surprises during review.
Required documents: Certificates of Free Sale, FDA 510(k) summaries, ISO 13485 quality system certificates, device risk analysis (ISO 14971), and IFUs translated to Chilean Spanish. SysMed provides the complete ISP submission package with all Resvent products pre-documented.
Why are lead times to Chile longer than other LATAM markets, and what are the options?
Geography. Chile is the farthest LATAM market from Miami, and that distance shows up in transit times. Ocean freight to San Antonio or Valparaíso runs 25–35 business days — roughly double the transit time to Caribbean coast destinations like Cartagena or Guayaquil.
The trade-off options: air freight to Santiago SCL cuts delivery to 2–5 business days but at significantly higher per-unit cost, making it viable for urgent orders or low-volume high-value shipments. For planned inventory replenishment, ocean freight remains cost-effective — the key is building lead time into your procurement calendar. SysMed works with Chilean partners on demand forecasting to align order timing with delivery windows.
Ready to Supply Your Facilities in Chile?
Get wholesale pricing, ISP registration guidance, and logistics support from our LATAM specialists.